GlycoMimetics Inc (GLYC)

0.2364 -0.02 (-7.44%) USD  |  NASDAQ  |  Dec 27, 16:00
0.2386 0.00 (0.00%) After-Hours: 20:00
More

GlycoMimetics Research and Development Expense (Quarterly): 1.715M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 184.90M
Arbutus Biopharma Corp 14.27M
Revance Therapeutics Inc 11.38M
FibroGen Inc 21.71M
Cidara Therapeutics Inc 12.43M